Targeting CEACAM5 in NSCLC
Research Focus: Targeting CEACAM5 With Novel Antibody-Drug Conjugates in Nonsquamous Non-Small-Cell-Lung Cancer

Released: June 09, 2023

David Planchard
David Planchard, MD, PhD

Activity

Progress
1
Course Completed